13 October 2023FeaturesJurisdiction reportsNaomi Pearce and Kate Legge
A hard lesson learnt: Commonwealth v Sanofi
In June this year, the first Full Federal Court decision on this issue was handed down following a ten-year damages battle between the Commonwealth and Sanofi relating to Apotex’s ‘delayed’ launch of generic clopidogrel following PI.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@worldipreview.com
6 June 2023 Big pharma company picks pan-European venue for next leg of global dispute | IT issues potentially behind low revocation count | Nearly half a million opt-outs registered.
30 June 2026 Justices will consider whether trademark strength should generally be decided by a jury or a judge in a likelihood-of-confusion analysis, after a successful petition by nitro cold brew coffee company Rise.